Venus Concept Inc. (VERO)
NASDAQ: VERO · IEX Real-Time Price · USD
-0.017 (-2.66%)
May 17, 2024, 4:00 PM EDT - Market closed

Company Description

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.

The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system.

In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing.

The company is headquartered in Toronto, Canada.

Venus Concept Inc.
Venus Concept logo
Country Canada
Industry Medical Devices
Sector Healthcare
Employees 304
CEO Rajiv Kanishka Liyanaarchchie De Silva

Contact Details

235 Yorkland Blvd., Suite 900
Toronto, A6 M2J 4Y8
Ontario, Canada
Phone 877-848-8430 X117

Stock Details

Ticker Symbol VERO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001409269
CUSIP Number 92332W105
ISIN Number US92332W2044
Employer ID 06-1681204
SIC Code 3841

Key Executives

Name Position
Dr. Hemanth Jacob Varghese CFA, Ph.D. President and Chief Operating Officer
Ross J. Portaro Executive Vice President and GM of Global Sales and Marketing
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer and Director
Domenic Della Penna Executive Vice President and Chief Financial Officer
Michael Mandarello General Counsel and Corporate Secretary
William H. McGrail Executive Vice President of Technical Operations and Compliance
Anat Kotler Head of Marketing and Product Management
Anna Georgiadis Chief Human Resources Officer
Dr. Yoni Iger Head of Scientific and Clinical Affairs
Joyce Morris Head of Sales - Canada

Latest SEC Filings

Date Type Title
May 15, 2024 10-Q Quarterly Report
May 15, 2024 8-K Current Report
May 7, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Apr 29, 2024 ARS Filing
Apr 29, 2024 DEF 14A Other definitive proxy statements
Apr 25, 2024 EFFECT Notice of Effectiveness
Apr 24, 2024 8-K Current Report
Apr 17, 2024 EFFECT Notice of Effectiveness
Apr 17, 2024 8-K Current Report
Apr 16, 2024 UPLOAD Filing